Source: Annual Congress 2010 - Tuberculosis in children
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Altet, M. L. De Souza Galvao, I. Latorre, C. Milá, M. A. Gimenez, J. Solsona, A. Cantos, P. Lozano, J. Ruiz-Manzano, R. Gené, J. Caylá, V. Ausina, J. Dominguez (Barcelona, Madrid, Badalona, Bellaterra, Spain). Tuberculosis infection treatment: Their effect on the immune response in children. Eur Respir J 2010; 36: Suppl. 54, 3745

Member's Comments

No comment yet.

Related content which might interest you: Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Understanding the immune response to tuberculosis in children versus adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Immunology: the immune response to mild and asymptomatic natural infection with SARS-CoV-2, and vaccination in healthy adults Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Cellular and humoral immune response in non HIV infected tuberculous patients in Upper Egypt Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Assessment of humoral immune response and the incidence of acquired infections in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 174s Year: 2003 Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 BCG vaccination in childhood is not related to pulmonary immunity against M. tuberculosis in adults Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 A deficient immune response to viral infections predicts asthma persistence in children Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Dynamic changes of Th1-cell immune response to ESAT-6 and CFP-10 during anti-tuberculosis treatment Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity Source: International Congress 2015 – Screening strategies in TB Year: 2015 The diagnosis of latent tuberculosis infection in children with new immunologic tests Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 Treatment of latent tuberculosis infection: completion rates and adverse effects Source: Eur Respir J 2003; 22: Suppl. 45, 526s Year: 2003 Latent tuberculosis infection treatment in subjects with autoimmune diseases and T-cell interferon-γ responses Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis Year: 2009 Socioeconomic environment, humoral immune response and the incidence of acquired infections Source: Eur Respir J 2003; 22: Suppl. 45, 174s Year: 2003 Tuberculosis therapy: past, present and future Source: Eur Respir J 2002; 20: 87S-94S Year: 2002